9619797

Source:http://linkedlifedata.com/resource/pubmed/id/9619797

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0033607, umls-concept:C0036220, umls-concept:C0205210, umls-concept:C0205460, umls-concept:C1963724
pubmed:issue	7
pubmed:dateCreated	1998-8-4
pubmed:abstractText	To evaluate the clinical and biological impact of protease inhibitors on HIV-associated Kaposi's sarcoma.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8710219
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents, http://linkedlifedata.com/resource/pubmed/chemical/Didanosine, http://linkedlifedata.com/resource/pubmed/chemical/Dideoxynucleosides, http://linkedlifedata.com/resource/pubmed/chemical/HIV Protease Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Indinavir, http://linkedlifedata.com/resource/pubmed/chemical/Lamivudine, http://linkedlifedata.com/resource/pubmed/chemical/Reverse Transcriptase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Ritonavir, http://linkedlifedata.com/resource/pubmed/chemical/Saquinavir, http://linkedlifedata.com/resource/pubmed/chemical/Stavudine, http://linkedlifedata.com/resource/pubmed/chemical/Zalcitabine, http://linkedlifedata.com/resource/pubmed/chemical/Zidovudine
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0269-9370
pubmed:author	pubmed-author:BlanchardGG, pubmed-author:BlumLL, pubmed-author:CalvoFF, pubmed-author:DanneOO, pubmed-author:LebbéCC, pubmed-author:MorelPP, pubmed-author:PelletCC, pubmed-author:VérolaOO
pubmed:issnType	Print
pubmed:day	7
pubmed:volume	12
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	F45-9
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:9619797-AIDS-Related Opportunistic Infections, pubmed-meshheading:9619797-Adult, pubmed-meshheading:9619797-Anti-HIV Agents, pubmed-meshheading:9619797-Didanosine, pubmed-meshheading:9619797-Dideoxynucleosides, pubmed-meshheading:9619797-Drug Therapy, Combination, pubmed-meshheading:9619797-Female, pubmed-meshheading:9619797-HIV Protease Inhibitors, pubmed-meshheading:9619797-Herpesvirus 8, Human, pubmed-meshheading:9619797-Humans, pubmed-meshheading:9619797-Indinavir, pubmed-meshheading:9619797-Lamivudine, pubmed-meshheading:9619797-Male, pubmed-meshheading:9619797-Middle Aged, pubmed-meshheading:9619797-Prospective Studies, pubmed-meshheading:9619797-Reverse Transcriptase Inhibitors, pubmed-meshheading:9619797-Ritonavir, pubmed-meshheading:9619797-Saquinavir, pubmed-meshheading:9619797-Sarcoma, Kaposi, pubmed-meshheading:9619797-Stavudine, pubmed-meshheading:9619797-Treatment Outcome, pubmed-meshheading:9619797-Viral Load, pubmed-meshheading:9619797-Viremia, pubmed-meshheading:9619797-Zalcitabine, pubmed-meshheading:9619797-Zidovudine
pubmed:year	1998
pubmed:articleTitle	Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma.
pubmed:affiliation	Department of Dermatology, Hôpital Saint-Louis, Paris, France.
pubmed:publicationType	Journal Article